This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Mar 25;115(12):2333-4.

doi: 10.1182/blood-2009-12-254532.

Iron chelation therapy: you gotta have heart

Affiliations

PMID: 20339104
DOI: 10.1182/blood-2009-12-254532

Free article

Comment

Iron chelation therapy: you gotta have heart

Alan R Cohen. Blood. 2010.

Free article

. 2010 Mar 25;115(12):2333-4.

doi: 10.1182/blood-2009-12-254532.

Author

Affiliation

¹ The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, USA.

PMID: 20339104
DOI: 10.1182/blood-2009-12-254532

No abstract available

PubMed Disclaimer

Comment on

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia.
Pennell DJ, Porter JB, Cappellini MD, El-Beshlawy A, Chan LL, Aydinok Y, Elalfy MS, Sutcharitchan P, Li CK, Ibrahim H, Viprakasit V, Kattamis A, Smith G, Habr D, Domokos G, Roubert B, Taher A. Pennell DJ, et al. Blood. 2010 Mar 25;115(12):2364-71. doi: 10.1182/blood-2009-04-217455. Epub 2009 Dec 8. Blood. 2010. PMID: 19996412 Clinical Trial.

Similar articles

"YOU GOTTA HAVE HEART".
JONES JL. JONES JL. J Okla State Med Assoc. 1964 Oct;57:463-8. J Okla State Med Assoc. 1964. PMID: 14199363 No abstract available.
"You Gotta Have Heart,".
Committee on Occupational Health, California Medical Association. Committee on Occupational Health, California Medical Association. Calif Med. 1962 Jun;96(6):435. Calif Med. 1962. PMID: 18732533 Free PMC article. No abstract available.
You gotta have heart.
Jones JL. Jones JL. J Okla State Med Assoc. 1972 Aug;65(8):343-9. J Okla State Med Assoc. 1972. PMID: 5052983 No abstract available.
The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major.
Di Maggio R, Maggio A. Di Maggio R, et al. Br J Haematol. 2017 Sep;178(5):676-688. doi: 10.1111/bjh.14712. Epub 2017 Apr 25. Br J Haematol. 2017. PMID: 28439891 Review.
Concepts and goals in the management of transfusional iron overload.
Porter JB. Porter JB. Am J Hematol. 2007 Dec;82(12 Suppl):1136-9. doi: 10.1002/ajh.21100. Am J Hematol. 2007. PMID: 17968973 Review.

See all similar articles

Cited by

Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs.
Kontoghiorghes GJ. Kontoghiorghes GJ. Int J Mol Sci. 2023 Nov 25;24(23):16749. doi: 10.3390/ijms242316749. Int J Mol Sci. 2023. PMID: 38069073 Free PMC article. Review.
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.
Kontoghiorghe CN, Kontoghiorghes GJ. Kontoghiorghe CN, et al. Drug Des Devel Ther. 2016 Jan 29;10:465-81. doi: 10.2147/DDDT.S79458. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 26893541 Free PMC article. Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems